AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2019
Mar 29, 2019
33090_dirs_2019-03-29_0af37aab-7cd5-467e-a98a-2a7afe19a604.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-03-29
Reporting Person: Lang James Paul (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-29 | Common Stock | A | 2084 | — | Acquired | 14585 | Direct |
Footnotes
F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.
More from OptimizeRx Corp
Board/Management Information
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23